SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing sharp selling pressure following quarterly guidance that fell short of expectations and a decision to reduce the frequency of engagement metric disclosures. The community is actively debating the company's long-term growth potential and content quality, with many investors weighing the significant recent share buybacks against broader concerns about streaming competition and valuation.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to the announcement of a new paid API service providing real-time access to high-profile posts, a move that has sparked intense debate among community members regarding potential conflicts of interest and market-moving information. The discussion is further fueled by polarizing reactions to a recent primetime address, with investors and social media users debating the platform's strategic direction, stock volatility, and the broader political controversy surrounding the former president.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense volatility as market participants debate whether recent price action is a fundamental shift or a temporary dealer-driven liquidity event. The community is sharply divided, with bulls pointing to strong demand for AI memory and solid growth projections, while bears cite broader sector rotation, geopolitical risks, and potential overcapacity as reasons for further downside.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending as investors weigh strong quarterly results and solid robotic procedure growth against persistent concerns regarding competitive pressures, potential ACA-related headwinds, and slowing momentum in key international markets. The community remains divided, with many viewing the recent pullback as a generational buying opportunity for a dominant medical robotics leader, while others express caution over elevated valuations and the impact of weight-loss drugs on long-term surgical demand.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings is trending due to a major $1 billion acquisition deal of ACEA Pharma, which has sparked intense speculation among retail traders regarding a potential short squeeze. The community is actively discussing the stock's extremely low float and rising cost-to-borrow, leading to aggressive buy-and-hold sentiment and hopes for significant price appreciation.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen is trending as market participants debate the stock's turnaround potential, fueled by the launch of a popular new wrap menu and recent institutional stake-building. While some investors view the product innovation and strategic leadership hires as catalysts for a long-term recovery, others remain skeptical, focusing on the company's historical cash burn and high short interest.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing intense volatility and downward pressure as investors grapple with shifting sentiment around AI-related capital expenditures and broader geopolitical tensions in the Middle East. Market participants are actively debating whether the current pullback represents a healthy corrective reset for tech valuations or the beginning of a more sustained structural shift in market leadership.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is facing significant downward pressure following the FDA's issuance of a Complete Response Letter (CRL) for its Hunter syndrome gene therapy, RGX-121, which necessitates additional clinical trials and data. Investors are now actively debating the company's long-term viability, focusing on its remaining cash runway and shifting their attention toward upcoming clinical readouts for the Duchenne muscular dystrophy program as the primary catalyst for recovery.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate its pivot toward agentic AI orchestration, with the community split between bulls betting on a potential short squeeze fueled by massive trading volume and skeptics concerned by persistent price stagnation. Traders are closely monitoring the stock's ability to hold the twelve-dollar level, highlighting its GAAP profitability and aggressive share buyback program as key defensive metrics against high short interest.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending as investors debate the stock's potential for a major breakout, with proponents pointing to expanding crypto services and institutional buybacks while skeptics remain focused on technical resistance levels and historical volatility. The community is actively tracking the stock's struggle to break past its current trading range, with many comparing its long-term potential to other fintech leaders despite persistent skepticism regarding its recent performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GENB Didn&#39;t expect the rebound this strong :) LFG!

JohnStockDon

StockTwits Web

Generate Biomedicines Inc

 Didn't expect the rebound this strong :) LFG!

d34dpoolish

@deadpoolish The Assembly 
@InTheAssembly 
· 
2h 
GENB Generate Biomedicines. 
 
Clinical-stage biotech using generative AI to design new proteins and therapeutics from scratch. 
 
They call it Generative Biology. Founded 2018 by Flagship Pioneering. HQ Somerville, MA. 
 
This is what AI in drug discovery actually looks like.

 
· 
2h 
GENB Generate Biomedicines. 
 
Clinical-stage biotech using generative AI to design new proteins and therapeutics from scratch. 
 
They call it Generative Biology. Founded 2018 by Flagship Pioneering. HQ Somerville, MA. 
 
This is what AI in drug discovery actually looks like.